Synthesizing process of 4-methoxy-alpha-[(3-methoxyphenyl)sulfo]-acetophenone
A technology of methoxyacetophenone and methoxythiophenol ethanol, which is applied in the field of synthesis of pharmaceutical intermediates, can solve the problems of increased cost, unimprovable yield, difficult solids, etc., and achieves production cost saving and solvent reduction. The effect of using and saving raw materials
Inactive Publication Date: 2010-08-25
SHANDONG XINHUA PHARMA CO LTD
View PDF4 Cites 2 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
The disadvantages of this process are: (1) The batch feeding is not uniform, the feeding must be cooled in ice salt water, and the added solids are difficult to dissolve in the solution, resulting in incomplete reaction and more impurities
(2) Based on the incomplete reaction, the post-treatment of the reaction product is complicated, and two new solvents are needed for extraction and refining, resulting in a decrease in yield, an increase in cost, and an increase in three wastes
However, this process still involves solvent distillation, ethyl acetate extraction and methanol refining, etc., and the yield cannot be improved.
And the mixed organic solvent of ethanol and ethyl acetate is used, and the manufacturing cost is still too high
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
Embodiment 2
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
The invention relates to a synthesizing process of 4-methoxy-alpha-[(3-methoxyphenyl)sulfo]-acetophenone, belonging to the synthesizing technique of medical intermediates. The synthesizing process comprises the following steps of dissolving alpha-bromo-4-methoxyphenyl-acetophenone in ethanol, and obtaining the 4-methoxy-alpha-[(3-methoxyphenyl)sulfo]-acetophenone by adding the mixed liquid of potassium hydroxide solution and 3-methoxy-thiophenol ethanol solution. The invention has the advantages of convenient operation, low cost, high purity and high yield rate.
Description
technical field The invention relates to a synthesis process of α-[(3-methoxyphenyl)thio]-4-methoxyacetophenone, which belongs to the synthesis technology of pharmaceutical intermediates. Background technique Raloxifene (English name: raloxifene) is an osteoporosis treatment drug developed by Eli Lilly. In the synthesis process of the drug, the common synthetic route takes 3-methoxythiophenol and α-bromo-4-methoxyacetophenone as starting materials, and undergoes condensation, cyclization, acylation and dehydration. Methylation and other reactions obtained. Wherein α-[(3-methoxyphenyl)thio]-4-methoxyethanone is the intermediate product of the first-step condensation reaction in the preparation process of raloxifene (as shown in the figure below): In the preparation of α-[(3-methoxyphenyl)thio]-4-methoxyacetophenone intermediates, there are not many reported preparation conditions. Wherein U.S. Patent (US 6472531, US 5523416) reported method is: first dissolve 3-methoxy t...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C323/22C07C319/14
Inventor 卢作勇郭统山陈瑜徐英
Owner SHANDONG XINHUA PHARMA CO LTD
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com